Intravenous bupropion: A previously undocumented method of abuse of a commonly prescribed antidepressant agent

Journal of Addiction Medicine

Volumn 7, Issue 3, 2013, Pages 216-217

  Baribeau, Danielle ^a   Araki, Keyghobad Farid ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Addiction; Bupropion; Injection drug use; Prescription drug abuse

Indexed keywords

AMFEBUTAMONE; BUPRENORPHINE; LITHIUM; OLANZAPINE; VALPROATE SEMISODIUM; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG INDICATION; FEMALE; HUMAN; MAINTENANCE THERAPY; PHYSICAL EXAMINATION; PRESCRIPTION; PRIORITY JOURNAL; VASCULAR ACCESS; VITAL SIGN; DOSE RESPONSE; DRUG DEPENDENCE TREATMENT; DRUG OVERDOSE; INAPPROPRIATE PRESCRIBING; INTRAVENOUS DRUG ADMINISTRATION; MENTAL DISEASE; METHODOLOGY; PSYCHOLOGICAL ASPECT; SUBSTANCE ABUSE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG OVERDOSE; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; INJECTIONS, INTRAVENOUS; MENTAL DISORDERS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS;

MLCS; MLOWN;

EID: 84880985481     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3182824863     Document Type: Article

References (13)

1. e-CPS, Compendium of Pharmaceuticals and Specialties [database online]. Canadian Pharmacists Association, 2012. Available at: www.etherapeutics. ca. Accessed February 8, 2011.
2. Conway C, Nelson LA. The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity. J ECT 2001;17(3):216-218.
3. Dunner DL, Zisook S, Billow AA, et al. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. J Clin Psychiatry 1998;59(7):366-373.
4. Foster R, Olajide D. A case of clozapine-induced tonic-clonic seizures managed with valproate: implications for clinical care. J Psychopharmcol 2005;19(1):93-96.
5. Khurshid K, Decker D. Bupropion insufflation in a teenager. J Child Adol Psychop 2004;14(1):157-158.
6. Kim D, Steinhart B. Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. Can J Emerg Med 2010;12(2):158-161.
7. Langguth B, Hajak G, Landgrebe M, et al. Abuse potential of bupropion nasal insufflation: a case report. J Clin Psychopharmacol 2009;29(6):618-619.
8. McCormick J. Recreational bupropion abuse in a teenager. J Clin Pharmacol 2002;53, 211-214.
9. Miller L, Griffith J. A comparison of bupropion, dextramphetamine and placebo in mixed substance abusers. Psychopharmacology 1983;80, 199-205.
10. ®: misuse and abuse by incarcerated individuals. J Addict Nurs 2012;23(1):65-69.
11. Starr P, Klein-Schwartz W, Spiller H, et al. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am JEmerg Med 2009;27:911-915.
12. Spina E, Perucca E. Significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia 2002;43(Suppl 2):37-44.
13. Welsh C, Doyon S. Seizure induced by insufflation of bupropion. N Engl J Med 2002;347(12):951.